Recent publications on Cancer

Laya MB, Gallagher JC, Schreiman JS, Larson EB, Watson P, Weinstein L. Effect of postmenopausal hormonal replacement therapy on mammographic density and parenchymal pattern. Radiology. 1995;196(2):433-7. PubMed

Rubenstein SA. Why managed care should provide supportive therapies for cancer patients.  Manag Care. 1995;4(8):37-9. PubMed

Rubenstein SA. Improving access to supportive therapies for cancer patients.  Health Care Innov. 1995;5(3):25-9, 36. PubMed

Taylor VM, Taplin SH, Urban N, White E, Peacock S. Repeat mammography use among women ages 50-75. Cancer Epidemiol Biomarkers Prev. 1995;4(4):409-13. PubMed

Cella DF, Bonomi AE, Lloyd SR, Tulsky DS, Kaplan E, Bonomi P. Reliability and validity of the Functional Assessment of Cancer Therapy-Lung (FACT-L) quality of life instrument. Lung Cancer. 1995;12(3):199-220. PubMed

Taplin SH, Barlow W, Urban N, Mandelson MT, Timlin DJ, Ichikawa L, Nefcy P. Stage, age or co-morbidity and the direct costs of colon, prostate and breast cancer care. J Natl Cancer Inst. 1995;87(6):417-26. PubMed

Bonomi AE, Cella DF. Cross-cultural adaptation of the Functional Assessment of Cancer Therapy (FACT) measurement system for use in European oncology clinical trials. Quality of Life Newsletter, No. 12, Feb-May. 1995. Lyon, France: MAPI Research Institute. PubMed

Lazovich D, Weiss NS, Stevens NG, White E, McKnight B, Wagner EH. A case-control study to evaluate efficacy of screening for faecal occult blood. J Med Screen. 1995;2(2):84-9. PubMed

Mandelson MT, Wagner EH, Thompson RS. PSA screening: a public health dilemma. Annu Rev Public Health. 1995;16:283-306. PubMed

Selik RM, Chu SY, Ward JW. Trends in infectious disease and cancers among persons dying from human immunodeficiency virus infection, United States,1987-1992. Ann Intern Med. 1995;123(12):933-6. PubMed

Hernandez L, Cella DF, Bonomi AE, Corona M. Cross-cultural validation of the FACT quality of life instrument. Journal of Oncology Pharmacy Practice. 1995;1:29-30. PubMed

Thompson RS, Barlow WE, Taplin SH, Grothaus L, Immanuel V, Salazar A, Wagner EH. A population-based case-cohort evaluation of the efficacy of mammographic screening for breast cancer. Am J Epidemiol. 1994;140(10):889-901. PubMed

Sherman KJ, Daling JR, McKnight B, Chu J. Hormonal factors in vulvar cancer. A case-control study. J Reprod Med. 1994;39(11):857-61. PubMed

Handley MR, Stuart ME. The use of prostate specific antigen for prostate cancer screening: a managed care perspective. J Urol. 1994;152(5 Pt 2):1689-92. PubMed

Taplin SH, Taylor V, Montano D, Chinn R, Urban N. Specialty differences and the ordering of screening mammography by primary care physicians. J Am Board Fam Pract. 1994;7(5):375-86. PubMed

Taylor VM, Taplin SH, Urban N, Mahloch J, Majer KA. Medical community involvement in a breast cancer screening promotional project. Public Health Rep. 1994;109(4):491-9. PubMed

Taplin SH, Anderman C, Grothaus L, Curry S, Montano D. Using physician correspondence and postcard reminders to promote mammography use. Am J Public Health. 1994;84(4):571-4. PubMed

Curry SJ, Emmons KM. Theoretical models for predicting and improving compliance with breast cancer screening. Ann Behav Med. 1994;16(4):302-16. PubMed

Cella DF. (Prepared with Amy E. Bonomi). Manual: Functional Assessment of Cancer Therapy (FACT) Scales and the Functional Assessment of HIV Infection (FAHI) Scale, Version 3. Chicago, IL: Rush-Presbyterian-St. Luke's Medical Center, 1994. PubMed

Laya MB, Larson EB, Schreiman J, Gallagher JC, Watson P, Weinstein L. The effect of a regimen of post-menopausal hormonal replacement therapy on the mammographic image. J Gen Int Med. 1994;9 (Suppl): 32. PubMed